Medbio inks partnership with Graham Partner

Published: 24-Jul-2018

Private equity firm has acquired a majority stake in the Michigan-based injection moulder

Medbio has announced that Graham Partners, the private equity firm based in Philadelphia (US), has made a substantial investment in the company.

The Michigan-based injection moulder said the new partnership will allow Medbio to meet its strong growth objectives and ensure it continues to build momentum as Medbio expand in the medical device and biotechnology industries.

Chris Williams remains Medbio president and CEO as well as the entire management and employee team.

"Our success, in no small part, can be attributed to your confidence in Medbio and the growth you have provided over the years. Graham’s investment means that we are in an even better position to meet your needs, offer you additional technologies and capabilities, and strategically expand our facilities and footprint," the company said in a statement.

A certified ISO 13485:2016 contract manufacturer, Medbio operates from a 65,000 sq ft facility located in Grand Rapids. This is a cross-functional facility containing our engineering, quality, and manufacturing departments, along with all our business support departments.

The facility features 37 moulding presses ranging in size from 17-ton to 220-ton, contained in an ISO Class 8 certified cleanroom and a micro-moulding press contained in a modular, ISO Class 7 certified cleanroom. The facility contains four modular, ISO Class 7 certified cleanrooms for assembling and packaging finished products.

You may also like